These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31778467)

  • 21. Independent lesions of fixed drug eruption caused by trimethoprim-sulfamethoxazole and tenoxicam in the same patient: a rare case of polysensitivity.
    Ozkaya-Bayazit E
    J Am Acad Dermatol; 2004 Aug; 51(2 Suppl):S102-4. PubMed ID: 15280825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe hypersensitivity reaction upon rechallenge with trimethoprim-sulfamethoxazole in a patient with AIDS.
    Arnold PA; Guglielmo BJ; Hollander H
    Drug Intell Clin Pharm; 1988 Jan; 22(1):43-5. PubMed ID: 2965002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients.
    Absar N; Daneshvar H; Beall G
    J Allergy Clin Immunol; 1994 Jun; 93(6):1001-5. PubMed ID: 8006304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nonscarring sublamina densa bullous drug eruption.
    Roholt NS; Lapiere JC; Traczyk T; Chan LS; Woodley DT
    J Am Acad Dermatol; 1995 Feb; 32(2 Pt 2):367-71. PubMed ID: 7829742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
    Caumes E; Guermonprez G; Winter C; Katlama C; Bricaire F
    Clin Infect Dis; 1996 Dec; 23(6):1313-4. PubMed ID: 8953079
    [No Abstract]   [Full Text] [Related]  

  • 26. Cutaneous reactions to trimethoprim-sulfamethoxazole in Haitians.
    DeHovitz JA; Johnson WD; Pape JW
    Ann Intern Med; 1985 Sep; 103(3):479-80. PubMed ID: 3161443
    [No Abstract]   [Full Text] [Related]  

  • 27. [Desensitization to trimethoprim-sulfamethoxazole in patients with HIV infection].
    Piketty C; Gilqouin J; Kazatchkine M
    Ann Med Interne (Paris); 1996; 147(5):327-30. PubMed ID: 9033734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerance induction to cotrimoxazole.
    Nucera E; Schiavino D; Buonomo A; Del Ninno M; Sun JY; Patriarca G
    Allergy; 2000 Jul; 55(7):681-2. PubMed ID: 10921475
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe co-trimoxazole reaction in a man with AIDS.
    Shepherd J; Shepherd C; Tonozzi C; Boysen E
    J Am Board Fam Pract; 1995; 8(2):130-3. PubMed ID: 7778481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Treating through" hypersensitivity to co-trimoxazole in AIDS patients.
    Putterman C; Rahav G; Shalit M; Rubinow A
    Lancet; 1990 Jul; 336(8706):52. PubMed ID: 1973231
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug eruptions presenting at sites of prior radiation damage (sunlight and electron beam).
    Shelley WB; Shelley ED; Campbell AC; Weigensberg IJ
    J Am Acad Dermatol; 1984 Jul; 11(1):53-7. PubMed ID: 6234333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction.
    Pyle RC; Butterfield JH; Volcheck GW; Podjasek JC; Rank MA; Li JT; Harish A; Poe KL; Park MA
    J Allergy Clin Immunol Pract; 2014; 2(1):52-8. PubMed ID: 24565769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption.
    Ozkaya-Bayazit E; Bayazit H; Ozarmagan G
    Contact Dermatitis; 1999 Oct; 41(4):185-9. PubMed ID: 10515095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A New Rush Schedule for Cotrimoxazole Desensitization: A Report of 2 Cases.
    Rial Prado MJ; Rico Díaz MA; Cosgaya Ceballos A; Cuesta Herranz J
    J Investig Allergol Clin Immunol; 2018 Aug; 28(4):267-269. PubMed ID: 30073962
    [No Abstract]   [Full Text] [Related]  

  • 35. Adverse reaction to sulphonamides in a burned patient--a case report.
    Sawada Y
    Burns Incl Therm Inj; 1985 Dec; 12(2):127-31. PubMed ID: 2936433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing drug reactions to sulfonamides and other drugs in HIV infection: desensitization rather than rechallenge?
    Koopmans PP; Burger DM
    Pharm World Sci; 1998 Dec; 20(6):253-7. PubMed ID: 9972526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fixed drug eruption in an 8-month-old infant.
    Bharija SC; Singh M; Belhaj MS
    Dermatologica; 1988; 176(2):108. PubMed ID: 2967210
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.
    Piketty C; Gilquin J; Kazatchkine MD
    J Infect Dis; 1995 Aug; 172(2):611. PubMed ID: 7622921
    [No Abstract]   [Full Text] [Related]  

  • 39. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome.
    Gordin FM; Simon GL; Wofsy CB; Mills J
    Ann Intern Med; 1984 Apr; 100(4):495-9. PubMed ID: 6230976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fixed drug eruption due to cotrimexasole.
    Varsano I; Amir Y
    Dermatologica; 1989; 178(4):232. PubMed ID: 2527766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.